IVF Industry Trade Group Uses Advocacy Non-Profit to Push Money-Making Agenda
By Editor,
ReproTech Truths
| 04. 10. 2019
In the last few years, ASRM has aggressively courted RESOLVE, once a purely grassroots group of women helping women get support for infertility. RESOLVE’s grassroots nationwide membership was its crown jewel.
Eager to gain access to RESOLVE’s membership, Big Pharma, along with ASRM, have each made large cash infusions in the form of sponsorships and events.
![Coulter company](https://reprotechtruths.org/wp-content/uploads/2019/04/Coulter-company-300x182.png)
Industry Mouth Piece
RESOLVE has since become a lobbying group for the industry. Its well-compensated executive team gets paid by Coulter Companies, now MCI USA according to RESOLVE’s latest tax filings. The industry-funded team works alongside its corporate council, donors and advocates — a who’s who of IVF clinic owners and service providers — to mobilize consumers to do its bidding: lobby to get insurance companies to compensate the industry for dispensing IVF cycles. It opens up a large untapped revenue stream.
RESOLVE today announced its full embrace of ASRM with an email blast that reads in part:
“ASRM has committed to a three-year investment in RESOLVE’s Access to Care programs, which will allow for new staff resources to grow these important programs...
Related Articles
By Gilma Avalos, NBC | 07.03.2024
Image by Josh Appel from Unsplash
The dream of becoming parents is turning into a nightmare for hundreds of people caught up in a surrogacy money scandal.
Some of the individuals are facing infertility or medical challenges, seeing surrogacy as...
By Emma McDonald Kennedy
| 07.11.2024
Louise Perry’s recent article in The Spectator cautions against “The quiet return of eugenics,” a threat she locates in preimplantation genetic testing for polygenic disorders. The technology is billed as a way for parents undergoing IVF to select which embryo to implant based on information about each embryo’s genetic risk factors and traits. These reports, she says, give parents “a very full picture of the adult that embryo could become”––from their child’s risk of developing different diseases to their “likely...
By Sonia Suter and Naomi Cahn, PET | 07.01.2024
Image by Dusdn5959 from Wikimedia Commons
Since the US Supreme Court's 2022 decision to overturn Roe v Wade (see BioNews 1147), there have been worries about the future of IVF in the USA. Both abortion and IVF involve decisions...